Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Locally Advanced Rectal Cancer × toripalimab × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Triple Negative Breast Neoplasms 12 Nasopharyngeal Carcinoma 11 Carcinoma, Non-Small-Cell Lung 8 Breast Neoplasms 8 Esophageal Squamous Cell Carcinoma 7 Squamous Cell Carcinoma of Head and Neck 6 Neoplasms 6 Colorectal Neoplasms 6 Carcinoma, Renal Cell 5 Advanced Solid Tumor 5 Uterine Cervical Neoplasms 4 Recurrence 4 Small Cell Lung Carcinoma 3 Neoplasm Metastasis 3 Liver Neoplasms 3 Head and Neck Neoplasms 3 Carcinoma, Transitional Cell 3 Carcinoma, Hepatocellular 3 Stomach Neoplasms 2 Solid Tumor 2 Pancreatic Neoplasms 2 Oropharyngeal Neoplasms 2 NSCLC 2 Esophageal Neoplasms 2 Carcinoma, Squamous Cell 2 Urinary Bladder Neoplasms 1 Turcot syndrome 1 Stage IB-IIIB NSCLC 1 Solid Tumor, Adult 1 Solid Cancer 1

Interventions

Capecitabine 7 Oxaliplatin 5 Fluorouracil 3 tislelizumab 2 spartalizumab 2 Leucovorin 2 Irinotecan 2 toripalimab 1 sintilimab 1 irinotecan sucrosofate 1 camrelizumab 1 Thymalfasin 1 Radiotherapy, Intensity-Modulated 1 Radiation 1 Folfox protocol 1 Celecoxib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06281405 2026-01-27

TORCH-iTNT

Fudan University

Phase 2 Recruiting

Gastrointestinal

Locally Advanced Rectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡